Revenue FY2025
$16.0M
Net Income
$(199.0M)
EPS (Basic)
$-3.46
Net Margin
-1236.0%
ROE
-100.0%
Total Equity
$199.0M
Shares Out
63M
uniQure N.V. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2014–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 3 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
OrbiMed Advisors
OrbiMed Advisors
$83.3M
0.4%
(15.4%)
Maverick Capital
Lee Ainslie
$42.6M
0.3%
+32.6%
Holocene Advisors
Holocene Advisors
$2.8M
0.0%
NEW
Insider Transactions
Reading stored insider transactions…